skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Gemcitabine-Oxaliplatin Regimen (Code C64833)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Gemcitabine-Oxaliplatin Regimen

Definition: A regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer and testicular cancer. This regimen is currently being studied in a variety of other cancers.

Label: Gemcitabine-Oxaliplatin Regimen

NCI Thesaurus Code: C64833 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1699231  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
GEM-OX Regimen
Gemcitabine-Oxaliplatin Regimen
GEMOX Regimen

External Source Codes: 
PDQ Closed Trial Search ID 751389
PDQ Open Trial Search ID 751389 (check for NCI PDQ open clinical trial info)
UMLS CUI C1699231

Other Properties:
     Name Value (qualifiers indented underneath)
code C64833
DesignNote Source: Physician's Cancer Chemotherapy Drug Manual 2006
Legacy_Concept_Name Gemcitabine-Oxaliplatin_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom